Prospective associations of diabetes with 15 cancers in 2.2 million UK and Chinese adults.
[BACKGROUND] Diabetes has been associated with the risk of numerous cancers, but the causal relevance of many of these associations remains unclear.
- HR 2.04
APA
Liu B, Floud S, et al. (2025). Prospective associations of diabetes with 15 cancers in 2.2 million UK and Chinese adults.. Journal of the National Cancer Institute, 117(12), 2477-2487. https://doi.org/10.1093/jnci/djaf154
MLA
Liu B, et al.. "Prospective associations of diabetes with 15 cancers in 2.2 million UK and Chinese adults.." Journal of the National Cancer Institute, vol. 117, no. 12, 2025, pp. 2477-2487.
PMID
40674590
Abstract
[BACKGROUND] Diabetes has been associated with the risk of numerous cancers, but the causal relevance of many of these associations remains unclear.
[METHODS] We investigated associations between diabetes and risks of 15 cancers using Cox-regression and individual-level data from 2.2 million adults (334 978 incident cancer cases) in 3 prospective cohorts, UK Biobank, Million Women Study, and China Kadoorie Biobank. The potential impact of residual confounding was assessed by examining changes in diabetes-associated log hazard ratios (HRs) after adjustment for key confounders.
[RESULTS] In combined analyses of individual participant data from 3 studies, diabetes was positively associated with the risk of 11 cancers, most notably liver (HR = 2.04, 95% CI = 1.87 to 2.23), pancreas (HR = 1.62, 95% CI = 1.48 to 1.77), and bladder (HR = 1.44, 95% CI = 1.29 to 1.62) cancer. The positive associations of diabetes with cancers of the breast, endometrium, kidney, and esophageal adenocarcinoma were substantially attenuated (>50%) after adjustment for confounders. The risks were similar in UK and Chinese populations except for liver cancer for which the adjusted hazard ratio was greater in UK than Chinese adults (HR = 2.58, 95% CI = 2.28 to 2.92, vs HR = 1.61, 95% CI = 1.43 to 1.83; Phet = 2.5 x 10-6). For liver cancer, the excess risk associated with diabetes increased with increasing body mass index (Ptrend = 2.7 x 10-4) and alcohol intake (Ptrend = .02). Diabetes was inversely associated with incidence of prostate cancer (HR = 0.78, 95% CI = 0.73 to 0.85) but positively associated with mortality (HR = 1.25, 95% CI = 1.00 to 1.55).
[CONCLUSIONS] Diabetes increases the risk of liver, pancreatic, and bladder cancer in UK and Chinese populations. It may also have a lesser effect on stomach, colorectal cancer, and leukemia, but its associations with other cancers could well be explained by confounding and/or other biases.
[METHODS] We investigated associations between diabetes and risks of 15 cancers using Cox-regression and individual-level data from 2.2 million adults (334 978 incident cancer cases) in 3 prospective cohorts, UK Biobank, Million Women Study, and China Kadoorie Biobank. The potential impact of residual confounding was assessed by examining changes in diabetes-associated log hazard ratios (HRs) after adjustment for key confounders.
[RESULTS] In combined analyses of individual participant data from 3 studies, diabetes was positively associated with the risk of 11 cancers, most notably liver (HR = 2.04, 95% CI = 1.87 to 2.23), pancreas (HR = 1.62, 95% CI = 1.48 to 1.77), and bladder (HR = 1.44, 95% CI = 1.29 to 1.62) cancer. The positive associations of diabetes with cancers of the breast, endometrium, kidney, and esophageal adenocarcinoma were substantially attenuated (>50%) after adjustment for confounders. The risks were similar in UK and Chinese populations except for liver cancer for which the adjusted hazard ratio was greater in UK than Chinese adults (HR = 2.58, 95% CI = 2.28 to 2.92, vs HR = 1.61, 95% CI = 1.43 to 1.83; Phet = 2.5 x 10-6). For liver cancer, the excess risk associated with diabetes increased with increasing body mass index (Ptrend = 2.7 x 10-4) and alcohol intake (Ptrend = .02). Diabetes was inversely associated with incidence of prostate cancer (HR = 0.78, 95% CI = 0.73 to 0.85) but positively associated with mortality (HR = 1.25, 95% CI = 1.00 to 1.55).
[CONCLUSIONS] Diabetes increases the risk of liver, pancreatic, and bladder cancer in UK and Chinese populations. It may also have a lesser effect on stomach, colorectal cancer, and leukemia, but its associations with other cancers could well be explained by confounding and/or other biases.
MeSH Terms
Adult; Aged; Female; Humans; Male; Middle Aged; China; Confounding Factors, Epidemiologic; Diabetes Mellitus; Incidence; Liver Neoplasms; Neoplasms; Pancreatic Neoplasms; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; United Kingdom; Urinary Bladder Neoplasms; East Asian People
같은 제1저자의 인용 많은 논문 (5)
- A Retrospective Quality Audit of a Prostate Cancer Biobank Reveals Procurement Method as the Critical Determinant of Biospecimen Fitness-for-Purpose.
- Overexpression of TFF3 is Associated with Immune Infiltration, Molecular Subtypes, and Clinical Progression in Breast Cancer.
- Retraction Note: MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/β-catenin pathway in acute myeloid leukemia.
- Bronchial artery infusion of PD-1 inhibitors plus chemotherapy improves progression-free survival in advanced NSCLC: a prospective cohort study.
- Retraction Note: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.